| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622334 | Trends in Cardiovascular Medicine | 2017 | 12 Pages |
Abstract
NOAC therapy has become the standard for stroke prevention in patients with atrial fibrillation. Yet some patients suffer extracranial bleeding events or have other reasons to seek non-pharmacologic stroke protection. LAA occlusion with the WATCHMAN device has been proven safe and effective for such patients and is now recommended in current guidelines for this patient group; other devices also seek approval.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martin W. MD, FESC,